Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?
Roberto C. Delgado Bolton, Adriana K. Calapaquí Terán, Ken Herrmann, Stefano Fanti, Francesco Giammarile
Abstract
ABSTRACT: Studies with [ 68 Ga]Ga-labeled or [ 18 F]F-labeled fibroblast activation protein inhibitor compounds have demonstrated favorable characteristics for PET/CT imaging, making them especially interesting for digestive tumors. In this review, the recent evidence in this field and its potential clinical applications are discussed.
Topics & Concepts
MedicineGastrointestinal tractDigestive tractFibroblast activation protein, alphaNuclear medicineMolecular imagingRadiologyPathologyCancerInternal medicineBiologyIn vivoBiotechnologyPeptidase Inhibition and AnalysisNeuroendocrine Tumor Research AdvancesCardiac tumors and thrombi